Czechia, Dec. 5 -- Czechia based PROMEDICA PRAHA GROUP, a.s. has secured contract from Fakultni nemocnice Olomouc for Antineoplastic and immunomodulating agents - LP containing everolim and deferrasirox 2022. The value of the contract is worth 2402070 CZK.
Published by HT Digital Content Services with permission from Pivotal Sources....